Home > Celleration Salary

Celleration Salary

  • 95
  • 91
  • 76
Celleration average salary is $120,000, median salary is $120,000 with a salary range from $120,000 to $120,000.
Celleration salaries are collected from government agencies and companies. Each salary is associated with a real job position. Celleration salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
120,000
Average
120,000
Median
120,000
High
120,000
Total 1 Celleration Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Information Technology Project Manager 120,000-120,000 Boston, MA, 02101 2015 Celleration Information Technology Project Manager Salaries (1)
Celleration Boston, MA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Celleration salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Celleration Jobs
See more Celleration Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Celleration... Information
  • Celleration?, Inc
  • Industry: Medical Equipment
  • City: Eden Prairie, MN
  • Celleration?, Inc. a privately held medical device company was founded in 1999, to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology? utilizes ultrasonic sound waves to produce an energized mist of sterile saline in a non-contact fashion. Critical to the Company¡¯s strategy is ongoing clinical and scientific research to provide evidence supporting the efficacy of this new technology. The Company¡¯s initial clinical research focus has been the chronic diabetic foot ulcer market and it has recently completed a randomized, sham controlled multi center study in diabetic foot ulcers to pursue additional indications for the MIST Technology. Additional